Thank you to everyone at ACS who stopped by our booth these?past?two days! If you haven't met our team yet, say hi tomorrow at booth 4119.
QSimulate
软件开发
Boston，Massachusetts 2,005 位关注者
Leveraging the power of quantum mechanics to solve industrial-scale problems like never before.
关于我们
As QSimulate is expanding the team, we have multiple open positions including scientists, software engineers, project management, and business development. Our offices are located in Boston MA, Berkeley CA, and Ghent, Belgium. For technical positions, we also consider remote options. Please write to us at [email protected] for more information.
- 网站
-
https://qsimulate.com
QSimulate的外部链接
- 所属行业
- 软件开发
- 规模
- 11-50 人
- 总部
- Boston，Massachusetts
- 类型
- 私人持股
地点
QSimulate员工
动态
-
Thank you all who came and participated in the lively discussion with Woody Sherman and David Pearlman last Friday! It was epic!! In case you missed it, check out the link below to view on demand: https://lnkd.in/eDgnyNju
-
-
Today, Nikkei Tech Foresight featured the long-standing partnership between QSimulate and JSR. Since 2020, QSimulate’s QSP Materials has supported JSR’s Materials Informatics initiatives with a broadening scope over years. This partnership is a testament to QSimulate’s commitment to technical innovation and customer success. Read the article: https://lnkd.in/evXGCkZQ
-
Don't miss tomorrow's Future of In Silico Drug Discovery Forum!
QSimulate is excited to announce that Woody Sherman from Psivant Therapeutics and David Pearlman, on Feb. 28th, will exchange thoughts on the future of computational drug discovery. This event will be moderated by John F. Conway, and the registration link can be found here: https://lnkd.in/ewg-69_S
-
-
AWS HPC Blog today features an article on QUELO, QSimulate’s drug lead optimization solution based on cutting-edge quantum simulation technology. In this blog post, we review our recent development of a mixed-precision (FP64/FP32) simulation solution for QUELO, which has led to an order-of-magnitude reduction in computing cost. The QM-based lead optimization solution can now be performed using cost-effective instance series on AWS such as the G6e instances. Check out the blog post to explore the future of drug lead optimization. https://lnkd.in/eQVmSi7e
-
One week to go! Join Woody Sherman and David Pearlman next Friday (Feb. 28th) as they discuss their experience with computational drug discovery and share their thoughts on its future. Don't forget to register here! https://lnkd.in/eWHqkGYA
-
We have seen an incredible response to QuaiPa, which brings quantum accuracy to the computational design of peptide drugs! Check out more details here: https://lnkd.in/e9z4kG25
-
-
QSimulate is excited to announce that Woody Sherman from Psivant Therapeutics and David Pearlman, on Feb. 28th, will exchange thoughts on the future of computational drug discovery. This event will be moderated by John F. Conway, and the registration link can be found here: https://lnkd.in/ewg-69_S
-